How Does Tetrabenazine Work? Mechanism of Action Explained in Plain English

Tetrabenazine is a VMAT2 inhibitor that reduces the involuntary movements (chorea) of Huntington's disease. But what does that actually mean inside your body? This article breaks down how Tetrabenazine works — the neurons, the chemicals, and the mechanism of action — in language that doesn't require a pharmacology degree to understand.

First: What Causes Chorea in Huntington's Disease?

Huntington's disease (HD) is caused by a mutation in the huntingtin gene (HTT) — specifically, an abnormal expansion of CAG triplet repeats. This mutation causes progressive damage to neurons, especially in a brain region called the striatum (part of the basal ganglia).

The basal ganglia is a brain circuit that helps regulate movement. When HD destroys neurons in the striatum, it disrupts the normal balance of inhibitory and excitatory pathways in this circuit. The result is an imbalance — with too much excitatory dopamine signaling relative to inhibitory signals — which produces the characteristic involuntary, unpredictable movements of chorea (from the Greek word for "dance").

The Key Player: Dopamine

In HD, the relative excess of dopamine activity in the basal ganglia is a major driver of chorea. Dopamine is a neurotransmitter — a chemical messenger that neurons use to communicate with each other. Under normal circumstances, dopamine plays a critical role in coordinating movement. In HD, the neurodegeneration shifts the balance toward excessive dopaminergic signaling, contributing to the uncontrolled movements.

Tetrabenazine's mechanism targets this dopamine excess — specifically, how dopamine (and other monoamine neurotransmitters) are stored and released in neurons.

What Is VMAT2 and Why Does It Matter?

VMAT2 stands for Vesicular Monoamine Transporter 2. It's a protein that lives inside neurons — specifically inside tiny sacs called synaptic vesicles. VMAT2's job is to package monoamine neurotransmitters (dopamine, serotonin, norepinephrine, histamine) into these vesicles for storage until the neuron is ready to release them.

Think of VMAT2 as a loading dock. Neurotransmitters are the cargo. The vesicles are the shipping containers. When a nerve signal arrives, the containers are released and dump their contents into the synapse (the gap between neurons). Without VMAT2 doing its loading job, the neurotransmitters can't be stored or released effectively.

How Tetrabenazine Blocks VMAT2

Tetrabenazine is a reversible inhibitor of VMAT2 — it binds to the VMAT2 protein and temporarily blocks it from doing its loading job. With VMAT2 blocked:

Monoamine neurotransmitters (especially dopamine) can't be packaged into vesicles

The "cargo" stays outside the containers, where enzymes break it down

When the nerve fires, there is much less dopamine available to release into the synapse

Dopamine activity in the basal ganglia decreases — which helps restore balance and reduces chorea

Why Does Tetrabenazine Cause Side Effects?

The same mechanism that reduces chorea also explains most of Tetrabenazine's side effects. Depleting dopamine too much can cause:

Parkinsonism: Because Parkinson's disease is itself caused by dopamine depletion, Tetrabenazine can produce Parkinson-like symptoms (tremor, stiffness, slow movement).

Depression: Dopamine and serotonin play important roles in mood regulation. Depleting both contributes to depression risk — hence the boxed warning.

Sedation: Histamine depletion (a side effect of VMAT2 inhibition) contributes to drowsiness.

How Tetrabenazine Is Different from Antipsychotics

Before Tetrabenazine, doctors often used antipsychotics (like haloperidol) off-label for HD chorea. Antipsychotics reduce dopamine activity by blocking dopamine receptors — like locking the doors on the receiving end. Tetrabenazine, by contrast, reduces the amount of dopamine that can be released in the first place — reducing the supply rather than blocking the receptors.

This distinction matters because blocking dopamine receptors with antipsychotics long-term can cause receptor upregulation (the brain grows more receptors to compensate), which can lead to tardive dyskinesia — ironically, the same type of involuntary movement problem. Tetrabenazine's mechanism at the VMAT2 level does not carry this risk.

Learn more: What Is Tetrabenazine? Uses, Dosage and Facts | Tetrabenazine Side Effects: What to Expect.